As of Mar 27
| +0.01 / +0.28%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,023.60% increase from the last price of 3.56.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.